Overview:

Unity Confirm is the first-and-only non-invasive confirmation test for high-risk Unity Aneuploidy Screen results* that bridges the gap between screening and invasive diagnosis, bringing rapid CVS-like insights** within reach from a simple maternal blood draw. Join Dr. Jitsen Chang and fellow OB/GYN and frontline providers for a practical discussion on integrating Unity Confirm into your practice and how it can redefine clinical care for high-risk patients.

What you'll learn:

• How Unity Confirm can expand access to critical insights for patients who cannot, or choose not to, pursue invasive diagnostics
• Where Unity Confirm fits within the Unity Aneuploidy Screen pathway
• The impact on patient counseling after a high-risk Unity Aneuploidy Screen result*
• The growing body of clinical evidence behind our innovation of Fetal Cell Capture™ technology and Unity Confirm

‍

^{*Unity Confirm is not available for high-risk monosomy X pregnancies, twin or higher multiple pregnancies, vanishing twins, gestational carriers or egg donors, or for pregnancies >15 weeks 6 days gestation. Only available in the US.}

^{**Unity Confirm and rapid CVS both analyze fetal-derived trophoblast cells. Unity Confirm isolates individual cells via whole genome sequencing, which is performed on each cell separately, whereas rapid CVS is often performed via FISH. While rapid CVS may analyze more cells, WGS generates more data per cell. In both rapid CVS and fetal cell capture, mosaicism cannot be excluded. No medical decisions should be made based on Unity Confirm alone. Clinical correlation is necessary.}